---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-030751"
form_type: "8-K"
ticker: "FLNA"
cik: "0001069530"
company_name: "FILANA THERAPEUTICS, INC."
filed_at: "2026-09-18T20:16:04+00:00"
generated_at: "2026-09-18T20:16:42.147987+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Filana Therapeutics receives Nasdaq delisting notice over sub-$1.00 bid price

## Summary
- Received Nasdaq notice Sept 17, 2026; bid price below $1.00 for 30 consecutive business days.
- Non-compliant with Nasdaq Listing Rule 5550(a)(2) minimum bid price requirement.
- Has 180 calendar days until March 16, 2027 to regain compliance.
- Must close at $1.00+ for 10 consecutive business days; second 180-day period possible.
- Stock continues trading on Nasdaq Capital Market under symbol FLNA.

## SEC filing metadata
- accession: 0001437749-26-030751
- form_type: 8-K
- ticker: FLNA
- cik: 0001069530
- company_name: FILANA THERAPEUTICS, INC.
- filed_at: 2026-09-18T20:16:04+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069530/000143774926030751/0001437749-26-030751-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069530/000143774926030751/sava20260918_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-030751
- JSON: https://secwatch.observer/filing/0001437749-26-030751.json
- Plain text: https://secwatch.observer/filing/0001437749-26-030751.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.